In 1972, Svetlana Mojsov was a PhD student at Rockefeller University in New York City under the tutelage of biochemist Bruce Merrifield, who had developed a new, efficient way to produce peptides in a lab (for which he would win a Nobel Prize in 1984) called solid-phase peptide synthesis. For her doctoral thesis, Mojsov used this method to achieve something that had eluded researchers for decades: She successfully synthesized glucagon, a complex hormone the body produces to raise blood sugar levels when necessary, which was of particular interest to endocrinologists as a potential treatment for diabetes
The growing demand for pharmacological tools to support weight loss, beyond traditional lifestyle interventions, reflect a broader shift in how these powerful medications are being used in clinical practice
Many insurances, including Medicare, dont cover any medications used for weight loss alone (though there are proposals to change this)
Each question requires different controls, markers, and interpretation standards
10.1016/j.foodchem.2021.129471 34 FestaM.SansoneC.BrunetC.CrocettaF.Di PaolaL.LombardoM.et al (2020)